We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Characterisation of Nanomaterials in Commercial Products
Product News

Characterisation of Nanomaterials in Commercial Products

Characterisation of Nanomaterials in Commercial Products
Product News

Characterisation of Nanomaterials in Commercial Products


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Characterisation of Nanomaterials in Commercial Products "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Nanomaterials are known to be present in over 1300 commercial products. As a result of the European Union (EU) recently providing a precise definition of a nanomaterial for regulatory purposes, it has become important to be able to characterise nanomaterials reliably to understand their behaviour in contact with humans and the environment. 


LGC is an international life sciences measurement and testing company with a history stretching back 175 years, providing reference materials, genomics solutions and analytical testing products and services. It is home to several national government roles, including the UK National Measurement Laboratory, the Designated Institute for Chemical and Bio-measurement and the Government Chemist. 


The inorganic analysis team at LGC - led by Principal Scientist and Science Fellow, Dr Heidi Goenaga-Infante - has established world class expertise in size-based and number concentration analysis of nanomaterials using hyphenated techniques to support the development of reference methods and materials, with field flow fractionation coupled to ICP-MS (FFF-ICP-MS) being the centrepiece of their multi-modal analytical approach.


Dr Goenaga-Infante commented “Over the last 15 years, Field Flow Fractionation (FFF) coupled to ICP-MS and other sizing detectors has proven itself a powerful tool for the characterisation of nanomaterials. For complex samples FFF seemed the ideal choice for matrix separation/sample fractionation, enabling us to achieve selective detection and characterisation of nanomaterials, that otherwise would have been hampered by the matrix components”. 


Dr Goenaga-Infante added “Having decided that FFF was the technique for us, we approached the two leading FFF manufacturers. We selected Postnova Analytics as our vendor of choice on the basis of their fast response to queries, scientific credibility and knowledgeable technical research assistance. The Postnova AF2000 system works robustly online when coupled with ICP-MS if a systematic approach is undertaken. We very much look forward to extending this collaboration into a partnership for life.”


A notable project** where the FFF- ICP-MS has demonstrated its worth has been for the development of a methodology for the determination of number based concentration of silica nanoparticles with a diameter of approximately 80 nm in a complex serum sample. By itself, single particle ICP-MS failed to detect silica nanoparticles due to the high procedural blank for Si with the instrumentation available at the time. In addition, particle tracking analysis (PTA) failed to provide accurate number concentration data with a reasonable measurement uncertainty due to matrix interferences. By using flow FFF to separate the particles from the matrix with on-line PTA detection, LGC were able to accurately determine number-based concentration for silica nanoparticles of d < 100 nm in a complex biological matrix, with no requirement for chemical pre-treatment. 


The Postnova AF2000 is a high performance Flow Field-Flow Fractionation (FFF) platform for separation of proteins, macromolecules and nanoparticles. Modular in design, the AF2000 incorporates the combined experience, expertise and technological advances from Postnova Analytics' nearly two decades of leadership in FFF. Incorporating a range of FFF modules in a single integrated system to provide universal separation, the AF2000 offers more flexibility, better performance and more robust results than any system before.


Please note: The content above may have been edited to ensure it is in keeping with Technology Networks’ style and length guidelines.
Advertisement